Artículos de revistas sobre el tema "Dox-Induced Cardiotoxicity"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Dox-Induced Cardiotoxicity".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Sumneang, Natticha, Pongpan Tanajak y Thura Tun Oo. "Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity". Molecules 28, n.º 11 (24 de mayo de 2023): 4294. http://dx.doi.org/10.3390/molecules28114294.
Texto completoAmmar, El-Sayed M., Shehta A. Said, Ghada M. Suddek y Sally L. El-Damarawy. "Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats". Canadian Journal of Physiology and Pharmacology 89, n.º 4 (abril de 2011): 269–76. http://dx.doi.org/10.1139/y11-020.
Texto completoHamaamin, Karmand Salih y Tavga Ahmed Aziz. "Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management". Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 3 (10 de diciembre de 2022): 87–97. http://dx.doi.org/10.54133/ajms.v3i.90.
Texto completoZheng, Dong, Yi Zhang, Ming Zheng, Ting Cao, Grace Wang, Lulu Zhang, Rui Ni et al. "Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity". Clinical Science 133, n.º 13 (julio de 2019): 1505–21. http://dx.doi.org/10.1042/cs20181022.
Texto completoZhang, Wei, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang y Congxin Huang. "Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3". Oxidative Medicine and Cellular Longevity 2023 (14 de enero de 2023): 1–23. http://dx.doi.org/10.1155/2023/9966355.
Texto completoMao, Jin Ning, Ai Jun Li, Liang Ping Zhao, Lan Gao, Wei Ting Xu, Xiao Su Hong, Wen Ping Jiang y Jian Chang Chen. "PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats". Advanced Materials Research 912-914 (abril de 2014): 263–68. http://dx.doi.org/10.4028/www.scientific.net/amr.912-914.263.
Texto completoManeechote, Chayodom, Siriporn C. Chattipakorn y Nipon Chattipakorn. "Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity". Pharmaceutics 15, n.º 4 (7 de abril de 2023): 1182. http://dx.doi.org/10.3390/pharmaceutics15041182.
Texto completoKitakata, Hiroki, Jin Endo, Hidehiko Ikura, Hidenori Moriyama, Kohsuke Shirakawa, Yoshinori Katsumata y Motoaki Sano. "Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis". International Journal of Molecular Sciences 23, n.º 3 (26 de enero de 2022): 1414. http://dx.doi.org/10.3390/ijms23031414.
Texto completoda Cunha Menezes Souza, Leonardo, Meng Chen, Yuji Ikeno, Daisy Maria Fávero Salvadori y Yidong Bai. "The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine". Traditional Medicine and Modern Medicine 03, n.º 04 (diciembre de 2020): 239–54. http://dx.doi.org/10.1142/s2575900020300076.
Texto completoJiang, Lai, Yanping Gong, Yida Hu, Yangyang You, Jiawu Wang, Zhetao Zhang, Zeyuan Wei y Chaoliang Tang. "Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis". Oxidative Medicine and Cellular Longevity 2020 (29 de julio de 2020): 1–11. http://dx.doi.org/10.1155/2020/2405135.
Texto completoCheng, Xiaoli, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan y Yaling Han. "Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling". BioMed Research International 2020 (19 de octubre de 2020): 1–13. http://dx.doi.org/10.1155/2020/5923572.
Texto completoMiranda, Carlos J., Hortence Makui, Ricardo J. Soares, Marc Bilodeau, Jeannie Mui, Hajatollah Vali, Richard Bertrand, Nancy C. Andrews y Manuela M. Santos. "Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin". Blood 102, n.º 7 (1 de octubre de 2003): 2574–80. http://dx.doi.org/10.1182/blood-2003-03-0869.
Texto completoJiao, Yuheng, Yanyan Li, Jiayan Zhang, Song Zhang, Yafang Zha y Jian Wang. "RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway". Biomolecules 12, n.º 2 (12 de febrero de 2022): 299. http://dx.doi.org/10.3390/biom12020299.
Texto completoHu, Xiaoping, Huagang Liu, Zhiwei Wang, Zhipeng Hu y Luocheng Li. "miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice". Oxidative Medicine and Cellular Longevity 2019 (3 de noviembre de 2019): 1–13. http://dx.doi.org/10.1155/2019/1512326.
Texto completoBhagat, Anchit y Eugenie S. Kleinerman. "Neutrophils contribute to Doxorubicin-Induced Cardiotoxicity". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 111.23. http://dx.doi.org/10.4049/jimmunol.206.supp.111.23.
Texto completoYu, Yangsheng, Degang Guo y Lin Zhao. "MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b". Evidence-Based Complementary and Alternative Medicine 2022 (15 de julio de 2022): 1–13. http://dx.doi.org/10.1155/2022/4364779.
Texto completoMao, Meijiao, Wang Zheng, Bin Deng, Youhua Wang, Duan Zhou, Lin Shen, Wankang Niku y Na Zhang. "Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes". PLOS ONE 18, n.º 10 (12 de octubre de 2023): e0292124. http://dx.doi.org/10.1371/journal.pone.0292124.
Texto completoZhao, Yintao, Jingjing Sun, Wei Zhang, Meng Peng, Jun Chen, Lu Zheng, Xiangqin Zhang, Haibo Yang y Yuan Liu. "Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2". Oxidative Medicine and Cellular Longevity 2020 (3 de agosto de 2020): 1–11. http://dx.doi.org/10.1155/2020/3598715.
Texto completoWang, Tao, Chuqiao Yuan, Jia Liu, Liangyan Deng, Wei Li, Junling He, Honglin Liu, Liping Qu, Jianming Wu y Wenjun Zou. "Targeting Energy Protection as a Novel Strategy to Disclose Di’ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin". International Journal of Molecular Sciences 24, n.º 2 (4 de enero de 2023): 897. http://dx.doi.org/10.3390/ijms24020897.
Texto completoWang, Jingya, Lin Yao, Xiaoli Wu, Qi Guo, Shengxuan Sun, Jie Li, Guoqi Shi, Ruth B. Caldwell, R. William Caldwell y Yongjun Chen. "Protection against Doxorubicin-Induced Cardiotoxicity through Modulating iNOS/ARG 2 Balance by Electroacupuncture at PC6". Oxidative Medicine and Cellular Longevity 2021 (20 de marzo de 2021): 1–17. http://dx.doi.org/10.1155/2021/6628957.
Texto completoLue, Yanhe, Chen Gao, Ronald Swerdloff, James Hoang, Rozeta Avetisyan, Yue Jia, Meng Rao et al. "Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity". American Journal of Physiology-Heart and Circulatory Physiology 315, n.º 3 (1 de septiembre de 2018): H634—H643. http://dx.doi.org/10.1152/ajpheart.00155.2018.
Texto completoLi, Jing, Huiping Liu, Srinivasan Ramachandran, Gregory B. Waypa, Jun-Jie Yin, Chang-Qing Li, Mei Han et al. "Grape Seed Proanthocyanidins Ameliorate Doxorubicin-Induced Cardiotoxicity". American Journal of Chinese Medicine 38, n.º 03 (enero de 2010): 569–84. http://dx.doi.org/10.1142/s0192415x10008068.
Texto completoSmuder, Ashley J., Andreas N. Kavazis, Kisuk Min y Scott K. Powers. "Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals". Journal of Applied Physiology 115, n.º 2 (15 de julio de 2013): 176–85. http://dx.doi.org/10.1152/japplphysiol.00924.2012.
Texto completoAshour, Abdelkader E., Mohamed M. Sayed-Ahmed, Adel R. Abd-Allah, Hesham M. Korashy, Zaid H. Maayah, Hisham Alkhalidi, Mohammed Mubarak y Abdulqader Alhaider. "Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats". Oxidative Medicine and Cellular Longevity 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/434195.
Texto completoLi, Ling-Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Wei Deng y Qi-Zhu Tang. "Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway". BioMed Research International 2020 (8 de junio de 2020): 1–11. http://dx.doi.org/10.1155/2020/8593617.
Texto completoLi, Siying, Wenjuan Wang, Ting Niu, Hui Wang, Bin Li, Lei Shao, Yimu Lai et al. "Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction". Oxidative Medicine and Cellular Longevity 2014 (2014): 1–15. http://dx.doi.org/10.1155/2014/748524.
Texto completoHaesen, Sibren, Manon Marie Jager, Aline Brillouet, Iris de Laat, Lotte Vastmans, Eline Verghote, Anouk Delaet et al. "Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity". Antioxidants 13, n.º 1 (17 de enero de 2024): 112. http://dx.doi.org/10.3390/antiox13010112.
Texto completoShan, Lingling, Yulong Huo, Siyu Li, Wanrong Li, Jing Wang, Yang Yang, Langzi Wang y Lin Chen. "Geraniin-Based Self-Assemble Nanoplatform for Antioxidation Reduced Cardiotoxicity and Tumor Synergistic Therapy". Journal of Biomedical Nanotechnology 19, n.º 5 (1 de mayo de 2023): 758–69. http://dx.doi.org/10.1166/jbn.2023.3580.
Texto completoOno, Masaya, Yoichi Sunagawa, Saho Mochizuki, Takahiro Katagiri, Hidemichi Takai, Sonoka Iwashimizu, Kyoko Inai et al. "Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis". Cancers 14, n.º 3 (28 de enero de 2022): 683. http://dx.doi.org/10.3390/cancers14030683.
Texto completoJiang, Yu, Yanjuan Liu, Wen Xiao, Dandan Zhang, Xiehong Liu, Huiqiong Xiao, Sanli You y Lili Yuan. "Xinmailong Attenuates Doxorubicin-Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO-1". Oxidative Medicine and Cellular Longevity 2021 (27 de marzo de 2021): 1–11. http://dx.doi.org/10.1155/2021/5896931.
Texto completoTaylor, Justin R. y Kyra Harames. "Abstract 4771: Prevention of doxorubicin-induced cardiotoxicity by benfotiamine". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4771. http://dx.doi.org/10.1158/1538-7445.am2023-4771.
Texto completoKoczurkiewicz-Adamczyk, Paulina, Katarzyna Klaś, Agnieszka Gunia-Krzyżak, Kamil Piska, Kalina Andrysiak, Jacek Stępniewski, Sławomir Lasota et al. "Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin". International Journal of Molecular Sciences 22, n.º 12 (9 de junio de 2021): 6217. http://dx.doi.org/10.3390/ijms22126217.
Texto completoLiu, Yuzhou, Liying Zhou, Binbin Du, Yuan Liu, Junhui Xing, Sen Guo, Ling Li y Hongrui Chen. "Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway". Oxidative Medicine and Cellular Longevity 2021 (6 de agosto de 2021): 1–18. http://dx.doi.org/10.1155/2021/9984330.
Texto completoLee, Eun Ji, Woong Bi Jang, Jaewoo Choi, Hye Ji Lim, Sangmi Park, Vinoth Kumar Rethineswaran, Jong Seong Ha et al. "The Protective Role of Glutathione against Doxorubicin-Induced Cardiotoxicity in Human Cardiac Progenitor Cells". International Journal of Molecular Sciences 24, n.º 15 (28 de julio de 2023): 12070. http://dx.doi.org/10.3390/ijms241512070.
Texto completoEgwuatu, Ifeanyi Anthony, Chiadikobi Lawrence Ozoemena, Emeka Williams Ugwuishi, Christian Chiemeka Ozor, Augustine Oviosun y Favour Onwene. "Deciphering the Ameliorative Potential of 5, 7-dihydroxyflavone (Chrysin) on Doxorubicin-Induced Cardiotoxicity by Modulating Oxidative Stress in Rats". Scholars International Journal of Anatomy and Physiology 6, n.º 11 (23 de noviembre de 2023): 181–90. http://dx.doi.org/10.36348/sijap.2023.v06i11.005.
Texto completoAbdul Karim, Lubna Zuhair, Inam Sameh Arif y Fouad A. Al Saady. "Lipidomics application to explain acute cardiotoxicity induced by doxorubicin". Al Mustansiriyah Journal of Pharmaceutical Sciences 19, n.º 4 (1 de diciembre de 2019): 161–69. http://dx.doi.org/10.32947/ajps.v19i4.647.
Texto completoChen, Sida, Yang Huang, Suiqing Huang, Zhuoming Zhou, Kaizheng Liu, Jinyu Pan y Zhongkai Wu. "M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes". PLOS ONE 18, n.º 7 (27 de julio de 2023): e0288422. http://dx.doi.org/10.1371/journal.pone.0288422.
Texto completoHamada, Juri, Altansarnai Baasanjav, Natsumi Ono, Kazuya Murata, Koichiro Kako, Junji Ishida y Akiyoshi Fukamizu. "Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity". American Journal of Physiology-Heart and Circulatory Physiology 308, n.º 8 (15 de abril de 2015): H931—H941. http://dx.doi.org/10.1152/ajpheart.00703.2013.
Texto completoWang, Yuewen, Xu Chao, Fiaz ud Din Ahmad, Hailong Shi, Hania Mehboob y Waseem Hassan. "Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity". Cardiology Research and Practice 2019 (23 de diciembre de 2019): 1–8. http://dx.doi.org/10.1155/2019/7395239.
Texto completoLi, Jun, Weiguo Wan, Tao Chen, Suiyang Tong, Xuejun Jiang y Wanli Liu. "miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice". BioMed Research International 2019 (4 de julio de 2019): 1–11. http://dx.doi.org/10.1155/2019/1528278.
Texto completoGyongyosi, Alexandra, Nikolett Csaki, Agota Peto, Kitti Szoke, Ferenc Fenyvesi, Ildiko Bacskay y Istvan Lekli. "BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function". International Journal of Molecular Sciences 24, n.º 6 (9 de marzo de 2023): 5269. http://dx.doi.org/10.3390/ijms24065269.
Texto completoAl-Shabanah, Othman A., Abdulaziz M. Aleisa, Mohamed M. Hafez, Salim S. Al-Rejaie, Abdulaziz A. Al-Yahya, Saleh A. Bakheet, Mohamed M. Al-Harbi y Mohamed M. Sayed-Ahmed. "Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model". Oxidative Medicine and Cellular Longevity 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/619185.
Texto completoRäsänen, Markus, Joni Degerman, Tuuli A. Nissinen, Ilkka Miinalainen, Risto Kerkelä, Antti Siltanen, Janne T. Backman et al. "VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection". Proceedings of the National Academy of Sciences 113, n.º 46 (31 de octubre de 2016): 13144–49. http://dx.doi.org/10.1073/pnas.1616168113.
Texto completoHaesen, Sibren, Eline Verghote, Ellen Heeren, Esther Wolfs, Dorien Deluyker y Virginie Bito. "Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells". Cells 13, n.º 2 (9 de enero de 2024): 120. http://dx.doi.org/10.3390/cells13020120.
Texto completoLaw, David, Mitchel A. Magrini, Jacob A. Siedlik, Joan Eckerson, Kristen M. Drescher y Eric C. Bredahl. "Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity". Nutrients 15, n.º 18 (19 de septiembre de 2023): 4048. http://dx.doi.org/10.3390/nu15184048.
Texto completoLegi, Ashiq, Emma Rodriguez, Thomas K. Eckols, Cyrus Mistry y Prema Robinson. "Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity". Cancers 13, n.º 7 (6 de abril de 2021): 1732. http://dx.doi.org/10.3390/cancers13071732.
Texto completoTao, Rong-Hua, Masato Kobayashi, Yuanzheng Yang y Eugenie S. Kleinerman. "Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo/YAP-Mediated Apoptosis". Cancers 13, n.º 11 (1 de junio de 2021): 2740. http://dx.doi.org/10.3390/cancers13112740.
Texto completoZhang, Wen-Bin, Xin Lai y Xu-Feng Guo. "Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis". Oxidative Medicine and Cellular Longevity 2021 (26 de enero de 2021): 1–14. http://dx.doi.org/10.1155/2021/8860883.
Texto completoRong, Jing, Lizhong Li, Li Jing, Haiqin Fang y Shuangqing Peng. "JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes". International Journal of Toxicology 35, n.º 3 (2 de noviembre de 2015): 317–26. http://dx.doi.org/10.1177/1091581815614261.
Texto completoAshour, Osama M., Ashraf B. Abdel-Naim, Hossam M. Abdallah, Ayman A. Nagy, Ahmed M. Mohamadin y Essam A. Abdel-Sattar. "Evaluation of the Potential Cardioprotective Activity of Some Saudi Plants against Doxorubicin Toxicity". Zeitschrift für Naturforschung C 67, n.º 5-6 (1 de junio de 2012): 297–307. http://dx.doi.org/10.1515/znc-2012-5-609.
Texto completo